Maintenance outage: This site will be inaccessible from late evening Mar 7th thru Mar 8th. This is for scheduled technology upgrades by our global hosting service that are affecting numerous websites and online journals. Note that our submission site is still accessible during this period and processing of new submissions will not be affected.
Article Information
History
- November 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Marisa Holubar, MD1,*,
- Aruna Subramanian, MD1,†,
- Natasha Purington, PhD2,
- Haley Hedlin, PhD2,
- Bryan Bunning, MS2,
- Katharine S. Walter, PhD1,
- Hector Bonilla, MD1,
- Athanasia Boumis3,
- Michael Chen, MD4,
- Kimberly Clinton3,
- Liisa Dewhurst3,
- Carol Epstein, MD5,
- Prasanna Jagannathan, MD1,6,
- Richard H. Kaszynski, MD4,
- Lori Panu3,
- Julie Parsonnet, MD1,7,
- Elizabeth L. Ponder, PhD8,
- Orlando Quintero, MD1,
- Elizabeth Sefton, PhD8,
- Upinder Singh, MD1,6,
- Luke Soberanis3,
- Henry Truong, PharmD9,
- Jason R. Andrews, MD1,
- Manisha Desai, PhD2,
- Chaitan Khosla, PhD10,8 and
- Yvonne Maldonado, MD11,7
- 1Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA
- 2Quantitative Sciences Unit, Division of Biomedical Informatics Research, Department of Medicine, Stanford University, Palo Alto, CA, USA
- 3Stanford Center for Clinical Research, Stanford University, Stanford, CA, USA
- 4Stanford Solutions, Stanford University School of Medicine, Stanford, CA 94305, USA
- 5Carol L. Epstein MD Consulting LLC, Wellington, FL, USA
- 6Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA
- 7Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA
- 8Stanford ChEM-H, Stanford University, Stanford CA, USA
- 9Mariner Advanced Pharmacy Corp, San Mateo, California
- 10Departments of Chemistry and Chemical Engineering, Stanford University, Stanford, CA, USA
- 11Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA
- ↵*Correspondence:
Marisa Holubar, MD MS, Clinical Associate Professor of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Lane Building 145 Stanford, CA 94305, mholubar{at}stanford.edu - ↵†Alternate Correspondence:
Aruna Subramanian, MD, Clinical Professor of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, 300 Pasteur Drive, Lane Building 145 Stanford, CA 94305, asubram2{at}stanford.edu
Posted November 24, 2021.
Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
Author Videos